Efstratios Karagiannis
Efstratios Karagiannis publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer and Lipoproteins and Cardiovascular Health.
- World rank
- #1,573,717 of 1,633,909 ranked researchers
- Rank in Germany
- #84,116 of 86,443
- Works
- 15
- Citations
- 1
- Citations per work
- 0.1
What does Efstratios Karagiannis research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Endocrinology, Diabetes and Metabolism37% of their works
- 2Molecular Biology16% of their works
- 3Surgery16% of their works
- 4Immunology and Allergy10% of their works
- 5Epidemiology5% of their works
- 6Pulmonary and Respiratory Medicine5% of their works
Research topics
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Chronic Disease Management Strategies
- Glioma Diagnosis and Treatment
Which keywords describe Efstratios Karagiannis's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, AMP-Activated Protein Kinase, Metformin, Cholesterol-lowering and Statins.
- Temozolomide
- Hypoglycemia
- Glioblastoma
- Critical Care
- Chronic Conditions
- Statins
- Metformin
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Outcomes
- AMP-Activated Protein Kinase
- Cholesterol-lowering
- Aspirin
- Clopidogrel
- Diabetes
- Hyperglycemia
- Multimorbidity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Glycemic Control73 topics
- Insulin Therapy73 topics
- Cardiovascular Outcomes51 topic
- Type 2 Diabetes51 topic
- AMP-Activated Protein Kinase31 topic
- Metformin31 topic
- Cholesterol-lowering21 topic
- Statins21 topic
- Aspirin11 topic
- Chronic Conditions11 topic
- Clopidogrel11 topic
- Critical Care11 topic
- Diabetes11 topic
- Glioblastoma11 topic
- Hyperglycemia11 topic
- Hypoglycemia11 topic
- Multimorbidity11 topic
- Temozolomide11 topic
Where does Efstratios Karagiannis work?
Efstratios Karagiannis's main affiliation in the publication record is Takeda (Germany), Germany.
How many publications and citations does Efstratios Karagiannis have?
Science Explorer counts 15 works and 1 citations for Efstratios Karagiannis, ranking #1,573,717 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.